ASE rises by 0.88% as trading volume increases
According to ASE figures, the volume of traded shares reached approximately 6.7 million, with a total trading value of around JD18.2 million executed through 4,195 transactions.
Market performance showed mixed results among listed companies: share prices rose for 32 companies, declined for 27, while 36 companies' share prices remained unchanged. Petra
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Jordan News
10 hours ago
- Jordan News
Cairo Amman Bank Issues 2024 Sustainability Report Following Global Best Practices - Jordan News
Cairo Amman Bank Issues 2024 Sustainability Report Following Global Best Practices Cairo Amman Bank announced the release of its 2024 Sustainability Report, prepared in accordance with the Global Reporting Initiative (GRI) standards and the sustainability reporting guidelines issued by the Amman Stock Exchange. This underscores the bank's commitment to its social responsibility and its pivotal role in supporting the United Nations Sustainable Development Goals (SDGs). اضافة اعلان The report reviews the key achievements made by the bank during the year and reflects tangible progress in implementing its sustainability strategy across environmental, social, and governance (ESG) dimensions. It also highlights initiatives and projects executed or supported by the bank as a key partner, demonstrating its deep commitment to creating a positive and sustainable impact on local communities throughout the Kingdom. The report emphasizes the bank's contributions to supporting the green economy through financing sustainable infrastructure projects, reducing the environmental footprint of its operations, adopting responsible institutional practices, alongside promoting responsible investment and managing environmental and social risks. Furthermore, the report reflects the bank's commitment to the economic modernization vision by focusing on digital transformation, developing the skills and competencies of its employees, and enhancing diversity and gender equality. This is embodied in the launch of the strategic framework for empowering women within the institution. Through this report, Cairo Amman Bank reaffirms its ongoing approach of transparency and accountability, and the promotion of a culture of sustainability as an integral part of its institutional operations, contributing to building a more prosperous and sustainable future for society and the national economy. To view the report, please visit the website:
Ammon
18 hours ago
- Ammon
Bride slaps shocked guests with $500 fee
Ammon News - Ahead of getting hitched, one ballsy bride-to-be is arranging an 'absurd' marriage between her wedding guests' money and her personal bank account, hitting invitees with a steep attendance fee — as well as a GoFundMe gift request. 'Bride [is] renting a large estate for five days for a destination wedding,' ranted a Redditor of the unnamed nearly-wed. 'We were told, 'accommodations were taken care of,' and that we only needed to book flights/transportation.' 'Two months before the wedding she tells us that we each need to [send] $500 per person for accommodation costs,' the virtual complainer carped. Unfortunately, the grabby bride's surprises didn't end there. 'I checked the website,' added the sleuthy invitee. 'The venue fee includes access to the entire grounds, and the number of guests I've been told are coming [times] $500, [which] actually means she'll be making more than what the venue fee is.' On top of pocketing a tidy profit via wedding day well-wishers, the unabashed bride and groom are, too, urging guests to gift them with cash toward their post-nuptial bash. NYP
Ammon
20 hours ago
- Ammon
Hikma Pharmaceuticals to Invest $1B in U.S. Manufacturing & R&D Capabilities
Ammon News - Hikma Pharmaceuticals will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities. This new phase of investment will further expand Hikma's domestic capabilities to develop, produce and deliver a broad range of medicines. Hikma has operated in the US since 1991 and has spent more than $4 billion over the past 15 years to build, enhance and expand its US-based R&D and manufacturing capabilities and now has annual domestic capacity to produce more than 12 billion finished doses of essential medicines. Over this period, Hikma has provided patients with access to a wide range of generic medicines at a lower cost than branded products. The new phase of investment represents the Company's latest efforts to increase the volume of essential medicines it develops and produces across its R&D and manufacturing sites in Columbus and Cleveland, Ohio and in Cherry Hill and Dayton, New Jersey. This next phase of expansion will help to strengthen Hikma's portfolio of more than 800 medicines and increase the Company's US-based capacity to produce large volumes of high-quality and affordable medicines for American hospitals, providers and patients. 'We are proud to continue our ongoing investments in US manufacturing and R&D to better serve the needs of American patients,' said Dr. Hafrun Fridriksdottir, President, Hikma Rx. 'Hikma and our 2,300 dedicated US people are committed to supporting healthier communities nationwide by providing Americans with a steady and reliable supply of domestically produced quality medicines.'
